BMAL1 and glioblastoma: Our study adds to this body of work by demonstrating that a conservative set of circadian rhythm genes—including core genes (e.g., CLOCK, ARNTL, CRYs) and circadian-related genes (filtered from DEGs among three circadian core-gene patterns)—can effectively classify GBM patients.